Auckland, 22 October 2026 – Fisher & Paykel Healthcare Corporation Limited has disclosed unauthorised access to two employee email accounts and a subset of company files. The medical-device manufacturer said its products, manufacturing operations and supply chain were unaffected, while the system that maintains patient data showed no evidence of compromise.
The incident matters to Asian healthcare investors because operational continuity and data integrity are central to the value of a medical-technology company. The scope described by Fisher & Paykel Healthcare is confirmed by its market announcement, but the investigation remains active. The absence of current evidence of wider compromise is not the same as a final assurance that no additional exposure will emerge.
Unlock the Full Article
This article is exclusive to The Ledger Asia Subsribers / PAID members.
Already have an account? Log in here

